955 related articles for article (PubMed ID: 19640573)
1. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
2. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
3. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
4. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
[TBL] [Abstract][Full Text] [Related]
5. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
[TBL] [Abstract][Full Text] [Related]
6. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
7. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
[TBL] [Abstract][Full Text] [Related]
8. A comparison of clinical outcomes with regular- and low-profile totally implanted central venous port systems.
Teichgräber UK; Streitparth F; Cho CH; Benter T; Gebauer B
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):975-9. PubMed ID: 19085032
[TBL] [Abstract][Full Text] [Related]
9. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
[TBL] [Abstract][Full Text] [Related]
11. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.
Ignatov A; Hoffman O; Smith B; Fahlke J; Peters B; Bischoff J; Costa SD
Eur J Surg Oncol; 2009 Mar; 35(3):241-6. PubMed ID: 18329836
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of outcomes and survivals for two central venous access port systems.
Hou SM; Wang PC; Sung YC; Lee HH; Liu HT; Chen YH
J Surg Oncol; 2005 Jul; 91(1):61-6. PubMed ID: 15999349
[TBL] [Abstract][Full Text] [Related]
13. Central venous access ports in children treated for hematopoietic malignancies.
Bucki B; Tomaszewska R; Karpe J; Stoksik P; Sońta-Jakimczyk D; Szczepański T
Pediatr Hematol Oncol; 2008 Dec; 25(8):751-5. PubMed ID: 19065441
[TBL] [Abstract][Full Text] [Related]
14. [Venous thrombosis in relation to central venous catheters: pathogenesis, diagnosis, therapy, possibilities of prophylaxis].
Hájek R; Matýsková M
Vnitr Lek; 1995 Jun; 41(6):415-20. PubMed ID: 7676664
[TBL] [Abstract][Full Text] [Related]
15. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
16. Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices.
Sarper N; Zengin E; Corapçioglu F; Tugay M
Pediatr Hematol Oncol; 2006 Sep; 23(6):459-70. PubMed ID: 16849276
[TBL] [Abstract][Full Text] [Related]
17. Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer.
Kefeli U; Dane F; Yumuk PF; Karamanoglu A; Iyikesici S; Basaran G; Turhal NS
Eur J Cancer Care (Engl); 2009 Mar; 18(2):191-4. PubMed ID: 19267736
[TBL] [Abstract][Full Text] [Related]
18. [Application of long term subcutaneously implanted access into the central veins system of "PORT" type in the Clinic of Pediatry, Pediatric Hematology and Oncology in Zabrze--15 year own observations].
Bucki B; Tomaszewska R; Bubała H; Sońta-Jakimczyk D; Karpe J; Stoksik P
Wiad Lek; 2009; 62(2):93-8. PubMed ID: 20141056
[TBL] [Abstract][Full Text] [Related]
19. Advances in venous access devices and nursing management strategies.
Wickham RS
Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.
Jansen FH; van der Straaten HM; Roest M; Haas F; de Groot PG; Fijnheer R
Haematologica; 2005 Apr; 90(4):499-504. PubMed ID: 15820946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
